Primarily at the early stages of the disease, it plays a shielding role against hepatic steatosis [30], soon after enlargement of VAT, leptin resistance ensues, mostly due to suppression of cytokine3 (SCCS-3), which is involved in leptin inhibition when overexpressed, and insulin resistance. This evidence concerns the gene LEP and fatty liver disease.